Delivery Order SPE2DB20D2104-SPE2DB23FU22N
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,015.22 Firm Fixed Price contract is for the delivery of 4,560,862,883 units of Methotrexate 2.5 mg tablets. The contract has an ultimate completion date of May 9, 2023 and is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of METHOTREXATE 2.5 MG TABLET 100S, a prescription medication, with a ceiling value of $2,542.92 and a performance period ending on June 27, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Methotrexate 2.5 mg tablets. The delivery order has a ceiling value of $1,906.78 and an ultimate completion date of September 11, 2024. The contract is a firm-fixed price type. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide the specified medication to support the healthcare needs of military treatment facilities and other...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 2.5 mg methotrexate tablets in 100-count packages, with a ceiling value of $1,240.16 and a period of performance through July 2, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Methotrexate 2.5 mg tablets in quantities of 100 units, with a ceiling value of $2,119.10. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of METHOTREXATE 2.5 MG TABLET UD 20S, a pharmaceutical product, with a ceiling value of $14,326.92 and a performance period ending on May 19, 2025. The contract is a firm-fixed-price delivery order, and it is not designated as a set-aside contract. Amerisourcebergen Drug...
- This federal contract award is a delivery order (SPE2DB20D1100|SPE2DB25FY70K) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,174.36 firm-fixed-price contract is for the delivery of Methotrexate 2.5 mg tablets, a medication used to treat various conditions. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Methotrexate 2.5 mg tablets in quantities of 100 units, with a ceiling value of $10,409.17. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order and is scheduled for completion by September 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,951.56 Firm Fixed Price Delivery Order covers the supply of 4,565,087,756 units of Methotrexate 2.5 mg Tablets in 100-count bottles, with a completion date of July 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as the primary vehicle...
- The federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,565,843,623 units of Methotrexate 2.5 mg tablets. The $3,853.16 firm fixed-price award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of September 18, 2024 and does not use a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU22NDelivery Order
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,826.37 firm fixed-price contract is for the delivery of Methotrexate 2.5 mg tablets, with a completion date of July 3, 2023. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical medical commodities, to support military healthcare programs globally. The contract was not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 6/30/23 |